From: Vaccination coverage and timeliness in three South African areas: a prospective study
Site | Coverage (end of follow-up) | Timely vaccination | Given too early | Given too late | Not given (at end of follow-up) | |
---|---|---|---|---|---|---|
Polio 0 | Paarl | 99 (96-100) | 99 (96-100) | 0 (0-0) | 0 (0-0) | 1 (0-4) |
Umlazi | 100 (98-100) | 99 (97-100) | 0 (0-0) | 1 (0-1) | 0 (0-2) | |
Rietvlei | 99 (96-100) | 94 (91-97) | 0 (0-0) | 4 (3-6) | 1 (0-4) | |
Total | 100 (99-100) | 97 (96-98) | 0 (0-0) | 3 (2-3) | 0 (0-1) | |
BCG vaccine | Paarl | 99 (97-100) | 99 (97-100) | 0 (0-0) | 0 (0-0) | 1 (0-3) |
Umlazi | 100 (98-100) | 100 (98-100) | 0 (0-0) | 0 (0-0) | 0 (0-2) | |
Rietvlei | 99 (97-100) | 99 (97-100) | 0 (0-0) | 0 (0-0) | 1 (0-3) | |
Total | 99 (98-100) | 99 (98-100) | 0 (0-0) | 0 (0-0) | 1 (0-2) | |
Polio 1 | Paarl | 100 (98-100) | 92 (90-93) | 1 (0-2) | 7 (5-8) | 0 (0-2) |
Umlazi | 99 (98-100) | 88 (86-89) | 1 (0-3) | 10 (8-12) | 1 (0-2) | |
Rietvlei | 96 (92-98) | 72 (67-75) | 1 (0-4) | 22 (19-25) | 4 (2-8) | |
Total | 99 (98-99) | 85 (84-87) | 1 (1-2) | 12 (11-14) | 1 (1-2) | |
DPT1+Hib+HBV | Paarl | 100 (98-100) | 93 (90-94) | 0 (0-2) | 6 (4-8) | 0 (0-2) |
Umlazi | 99 (98-100) | 88 (86-89) | 1 (1-3) | 10 (8-12) | 1 (0-2) | |
Rietvlei | 97 (95-99) | 77 (73-79) | 2 (1-4) | 19 (16-21) | 3 (1-5) | |
Total | 99 (98-100) | 87 (85-88) | 1 (1-2) | 11 (10-12) | 1 (0-2) | |
Polio 2 | Paarl | 99 (97-100) | 94 (92-94) | 1 (0-2) | 4 (3-5) | 1 (0-3) |
Umlazi | 98 (96-99) | 90 (87-91) | 0 (0-2) | 8 (6-9) | 2 (1-4) | |
Rietvlei | 87 (82-91) | 72 (67-75) | 1 (0-3) | 14 (12-14) | 13 (9-18) | |
Total | 96 (94-97) | 87 (85-88) | 1 (0-1) | 8 (7-9) | 4 (3-6) | |
DPT2+Hib+HBV | Paarl | 99 (97-100) | 95 (93-95) | 0 (0-2) | 3 (2-4) | 1 (0-3) |
Umlazi | 98 (96-99) | 90 (88-91) | 0 (0-2) | 7 (6-8) | 2 (1-4) | |
Rietvlei | 92 (88-95) | 80 (75-82) | 0 (0-3) | 12 (10-13) | 8 (5-12) | |
Total | 97 (96-98) | 90 (88-91) | 0 (0-1) | 7 (6-8) | 3 (2-4) | |
Polio 3 | Paarl | 94 (91-96) | 93 (91-94) | 1 (0-3) | 0 (0-0) | 6 (4-9) |
Umlazi | 98 (96-99) | 87 (83-88) | 0 (0-2) | 11 (9-13) | 2 (1-4) | |
Rietvlei | 69 (62-75) | 64 (57-71) | 0 (0-0) | 5 (4-5) | 31 (25-38) | |
Total | 87 (85-89) | 84 (82-86) | 0 (0-1) | 2 (2-3) | 13 (11-15) | |
DPT3+Hib+HBV | Paarl | 94 (91-96) | 92 (90-93) | 1 (0-3) | 0 (0-0) | 6 (4-9) |
Umlazi | 90 (87-93) | 86 (83-88) | 0 (0-2) | 4 (3-4) | 10 (7-13) | |
Rietvlei | 74 (68-80) | 70 (64-73) | 0 (0-3) | 4 (4-4) | 26 (20-32) | |
Total | 88 (86-90) | 85 (83-86) | 1 (0-1) | 3 (3-3) | 12 (10-14) |